Completed PHASE1 INTERVENTIONAL 1-arm NCT05971849

Dampening the Reproductive Axis With Continuous Kisspeptin

Sponsor: Stephanie B. Seminara, MD

Conditions PCOS Polycystic Ovary Syndrome Reproductive Disorder

Updated 7 times since 2023 Last updated: Nov 3, 2025 Started: Oct 6, 2023 Primary completion: Apr 27, 2024 Completion: Apr 27, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on PCOS and Polycystic Ovary Syndrome, this trial is completed. The trial is conducted by Stephanie B. Seminara, MD and has accumulated 7 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Dec 2025 — Present [monthly]

Completed PHASE1

Status: Recruiting → Completed
Aug 2025 — Dec 2025 [monthly]

Recruiting PHASE1
Sep 2024 — Aug 2025 [monthly]

Recruiting PHASE1
Aug 2024 — Sep 2024 [monthly]

Recruiting PHASE1
Jul 2024 — Aug 2024 [monthly]

Recruiting PHASE1

▶ Show 2 earlier versions

Nov 2023 — Jul 2024 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Sep 2023 — Nov 2023 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Stephanie B. Seminara, MD

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States